At Broach Lifecare (Maple) Hospital, they take immense pride in being at the forefront of healthcare, with a dedicated focus on cardiac ailments. Their state-of-the-art facility boasts an ultra-modern cathlab, a testament to their commitment to providing the highest quality care to their patients.

Broach Lifecare Hospital, a Fixed Price Issue amounting to ₹4.02 crores, consisting entirely a Fresh Issue of 16.08 Lakh Shares. The subscription period for the Broach Lifecare Hospital IPO opens on August 13, 2024, and closes on August 16, 2024. The allotment is expected to be finalized on or about Monday, August 19, 2024, and the shares will be listed on the BSE NSE with a tentative listing date set on or about Wednesday, August 21, 2024.

The Share price of Broach Lifecare Hospital IPO is set at ₹25 equity per share, with a minimum lot size of 6,000 shares. Retail investors are required to invest a minimum of ₹150,000, while the minimum investment for High-Net-Worth Individuals (HNIs) is 2 lots (12,000 shares), amounting to ₹300,000.

FEDEX SECURITIES PRIVATE LIMITED is the book-running lead manager, KFIN TECHNOLOGIES LIMITED is the registrar for the Issue. Aftertrade Broking Private Limited (formerly known as RCSPL Share Broking Private Limited) will act as the Market Maker for the Broach Lifecare Hospital IPO.

Broach Lifecare Hospital Limited IPO GMP Today
The Grey Market Premium of Broach Lifecare Hospital Limited IPO is expected in the range of ₹2.5 to ₹3.5 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Broach Lifecare Hospital Limited IPO Allotment Status
Broach Lifecare Hospital IPO allotment date is 19 August, 2024, Monday. Broach Lifecare Hospital IPO Allotment will be out on 19th August 2024 and will be live on Registrar Website from the allotment date. Check Broach Lifecare Hospital Limited IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Broach Lifecare Hospital Limited IPO from the dropdown list of IPOs.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Broach Lifecare Hospital Limited IPO
Broach Lifecare Hospital Issue Proceeds from the Fresh Issue will be utilized towards the following objects : 
(i) ₹402.00 Lakhs is required for Purchase of Machineries; 
(ii) ₹45.00 Lakhs is required for Development of Medical Tourism Web Portal; and 
(iii) General Corporate Purpose

Refer to Broach Lifecare Hospital Limited RHP for more details about the Company.

Check latest IPO Review & analysis, Live GMP today, Live Subscription Status Today, Share Price, Financial Information, latest IPO news, Upcoming IPO News before applying in the IPO.

The Upcoming IPOs in this week and coming weeks are Brace Port Logistics Limited, Forcas Studio Limited, Interarch Building Products Limited.

The current active IPO is Positron Energy Limited IPO, Saraswati Saree Depot Limited, Sunlite Recycling Industries, Broach Lifecare (Maple) Hospital Limited, Solve Plastic Products Limited

The Recently Listed IPOs which is available for trading in stock Market are RNFI Services Limited, Sanstar Limited, Sahaj Solar Limited, Macobs Technologies Limited IPO, Kataria Industries Limited IPO, Sati Poly Plast Limited, Aelea Commodities Limited, Prizor Viztech Limited, Three M Paper Boards Limited, BANSAL WIRE INDUSTRIES, EMCURE PHARMACEUTICALS, NEPHRO CARE INDIA, Diensten Tech Limited, Vraj Iron and Steel Limited, Divine Power Energy Limited.

Read more

About Broach Lifecare (Maple) Hospital Limited

At Broach Lifecare (Maple) Hospital, they take immense pride in being at the forefront of healthcare, with a dedicated focus on cardiac ailments. Their state-of-the-art facility boasts an ultra-modern cathlab, a testament to their commitment to providing the highest quality care to their patients. They operate their boutique Hospitals under the brand “Maple Hospitals” and provide dedicated round-the-clock services to patients with heart ailments consisting of non-invasive cardiology services such as, 2D Echocardiography, Electrocardiography, Tread Mill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test, Dobutamine Stress Echocardiography. Subsequently, in the year June/July 2023 they ventured into interventional cardiac services such as, coronary angiography and stenting, percutaneous coronary intervention (“PCI”) and primary PCI for acute myocardial infarction as a division. They also provide Ballon mitral-valvuloplasty, permanent pacemaker implantation, cardiac resynchronisation procedures, implantable cardioverter-defibrillator (“AICD”) implantation and procedures for congenital ailments such as coarctation of aorta, stenting and posterior descending artery closure. They also offer a complete range of diagnostic and therapeutic options such as endovascular revascularization, deep vein thrombosis treatment and peripheral angioplasty.

They believe that their hospital in Bharuch is an ultra-luxury hospital with 25 beds for in-patient treatment and is also equipped with diagnostic devices for performing test such as, 2D Echocardiography, Electrocardiography, Tread Mill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test, Dobutamine Stress Echocardiography & high end Coronary care with life-saving equipment such as Intra-aortic Ballon Pump Machine, Biphasic Defibrillator, Ventilators, BIPAP machines, Syringe Pump, Volumetric Infusion Pumps and Multipara Monitoring Machines. They believe that they have capabilities to undertake complex intervention procedures using Cutter ballons for In-Stent blockages, Implanting Drug eluting Ballons in previously implanted stent, fractional flow reserve & rotablator technology for hard calcified blockages.

Their Satellite Hospital at Ankleshwar is a 15 bedded nursing home which act as a referral centre and offers non-surgical day-to-day treatment to our patients. The Satellite Hospital is also self-sustaining as they are strategically located to fulfil demand for basic tertiary care. Their hospitals are certified by the National Accreditation Board for Hospitals & Healthcare Providers (“NABH”) as a primary-level small healthcare organization. Their Hospital is having Certification of Atomic Energy Regulatory Board for PACS System & Fire safety certificate from local regulation bodies for safety of our patients. The Company is also a member of Globe Bio Care for the disposal of biomedical waste.

HEALTHCARE SECTOR IN INDIA
Healthcare has become one of India’s largest sectors, both in terms of revenue and employment. Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance and medical equipment. The Indian healthcare sector is growing at a brisk pace due to its strengthening coverage, services, and increasing expenditure by public as well as private players. 

India’s healthcare delivery system is categorised into two major components - public and private. The government, i.e., the public healthcare system, comprises limited secondary and tertiary care institutions in key cities and focuses on providing basic healthcare facilities in the form of Primary Healthcare Centers (PHCs) in rural areas. The private sector provides the majority of secondary, tertiary, and quaternary care institutions with a major concentration in metros, tier-I, and tier-II cities. 

India's competitive advantage lies in its large pool of well-trained medical professionals. India is also cost-competitive compared to its peers in Asia and Western countries. The cost of surgery in India is about one-tenth of that in the US or Western Europe. The low cost of medical services has resulted in a rise in the country’s medical tourism, attracting patients from across the world. Moreover, India has emerged as a hub for R&D activities for international players due to its relatively low cost of clinical research.

Indian Healthcare Market Scenario
➢ The Indian health care sector is expected to record a three-fold rise, growing at a CAGR of 22% between 2016– 22 to reach US$ 372 billion in 2022 from US$110 billion in 2016 
➢ As of August 18, 2023, more than 2.20 billion COVID-19 vaccine doses have been administered across the country. 
➢ By FY22, Indian healthcare infrastructure is expected to reach US$ 349.1 billion. 
➢ As of 2021, the Indian healthcare sector is one of India’s largest employers as it employs a total of 4.7 million people. The sector has generated 2.7 million additional jobs in India between 2017-22 over 500,000 new jobs per year. 
➢ India’s public expenditure on healthcare touched 2.1% of GDP in FY23 and 2.2% in FY22, against 1.6% in FY21, as per the Economic Survey 2022-23.

BROACH LIFECARE HOSPITAL LIMITED STRENGTHS
1. Clinical Excellence and Affordable Healthcare
2. Strategic location
3. Strong empanelment
4. Ability to attract and retain high quality doctors, consultants and medical support staff
5. Experienced Promoters, management team with a strong execution track record

BROACH LIFECARE HOSPITAL LIMITED STRATEGIES
1. Increase their service offerings through addition of equipment – Cath lab Machines
2. Medical Tourism and CRM software
3. Increasing their association and empanelment

BROACH LIFECARE HOSPITAL LIMITED RISK FACTORS & CONCERNS
1. The Company has been formed specifically for the purpose of acquisition of the business of Dr. Vyas’s Hospital (proprietorship concern of their Promoter i.e., Dr. Jaykumar Narendra Vyas) thus they have limited operating history as a Company which may make it difficult for investors to evaluate their historical performance or future prospects.
2. They are highly dependent on their doctors and other healthcare professionals.
3. Their operations are geographically located in Bharuch and Ankleshwar in Gujarat at present and any localized social unrest, natural calamities, etc. could have material adverse effect on business and financial operations.
4. They are a boutique hospital, primarily provide services relating to interventional cardiac services.
5. They derive a significant portion of their revenues from their tie up arrangements with insurance companies, third party administrators and corporations.
6. The Company is dependent on limited number of external suppliers for its medicine and consumables requirements.
7. Most of their radiology and diagnostic imaging equipment contain radioactive and nuclear materials or emit radiation during operation which could make them liable for damages.